| Timeframe | Predicted Price | Past | Historical | Insight |
|---|---|---|---|---|
| Tomorrow | $2.33 ▼ -1.06% | Yesterday | $2.36 ▲ +0.45% | Tomorrow's Lipocine Inc. Common Stock (LPCN) setup is anchored to $2.35 and targets $2.33 (-1.06%). The near-term read is downside; watch $2.42 / $2.28 because daily realized volatility is about 5.47%. |
Tomorrow's Lipocine Inc. Common Stock (LPCN) setup is anchored to $2.35 and targets $2.33 (-1.06%). The near-term read is downside; watch $2.42 / $2.28 because daily realized volatility is about 5.47%. | ||||
| Week | $2.27 ▼ -3.30% | Last Week | $2.38 ▲ +1.39% | The 7-day Lipocine Inc. Common Stock model moves from $2.38 to $2.27 (-3.30%). It gives downside momentum context for this stock, so breaks around $2.42 / $2.28 matter more than a single tick. |
The 7-day Lipocine Inc. Common Stock model moves from $2.38 to $2.27 (-3.30%). It gives downside momentum context for this stock, so breaks around $2.42 / $2.28 matter more than a single tick. | ||||
| Month | $2.18 ▼ -7.03% | Last Month | $2.42 ▲ +2.95% | The 1-month Lipocine Inc. Common Stock target is $2.18 (-7.03%), compared with the live reference near $2.35. This horizon blends current trend pressure with price momentum, liquidity, and company-specific risk. |
The 1-month Lipocine Inc. Common Stock target is $2.18 (-7.03%), compared with the live reference near $2.35. This horizon blends current trend pressure with price momentum, liquidity, and company-specific risk. | ||||
| Year | $2.05 ▼ -12.62% | Last Year | $2.47 ▲ +5.30% | The 1-year Lipocine Inc. Common Stock scenario points to $2.05 (-12.62%). Confidence is lower than short-term rows, so treat it as cycle context and re-check it after major market-data updates. |
The 1-year Lipocine Inc. Common Stock scenario points to $2.05 (-12.62%). Confidence is lower than short-term rows, so treat it as cycle context and re-check it after major market-data updates. | ||||
| 5 Years | $1.75 ▼ -25.71% | 5 Years Ago | $2.60 ▲ +10.80% | The 5-year Lipocine Inc. Common Stock view is $1.75 (-25.71%). It is a directional scenario built from bounded drift and volatility, not a guaranteed path. |
The 5-year Lipocine Inc. Common Stock view is $1.75 (-25.71%). It is a directional scenario built from bounded drift and volatility, not a guaranteed path. | ||||
| Indicator | Value | Signal |
|---|---|---|
| Price | $2.35 | Mid |
| Daily Change | +2.17% | Above |
| Volatility Cap | 20.0% | Mid |
| Confidence | 62% | Below |
| Data Source | nasdaq-screener | Mid |
| Current | $2.35 | Daily Change | +2.17% |
| Market Cap | $17.15M | Source | nasdaq-screener |
Related ideas for internal navigation, grouped by stronger upside and weaker downside setups in the same market.